Judith Malmgren1, Boya Guo1, Henry G Kaplan2. 1. Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA, United States of America. 2. Swedish Cancer Institute, Seattle, WA, United States of America.
Abstract
BACKGROUND: As the coronavirus (COVID-19) epidemic passed initial infection peak in Washington State, phased re-opening lifted stay-at-home orders and restrictions leading to increased non-essential work, social activities and gathering, especially among younger persons. METHODS: A longitudinal cohort analysis of Washington State Department of Health COVID-19 confirmed case age distribution 1) March-April 2020 (N = 13,934) and 2) March-August 2020 (N = 76,032) for proportional change over time using chi square tests for significance. RESULTS: From March 1st to April 19, 2020 COVID-19 age distribution shifted with a 10% decline in cases age 60 years and older and a 20% increase in age 0-19/20-39 years (chi-square = 223.10, p < .001). Number of cases over the initial analysis period were 0-19 years n = 515, 20-39 years n = 4078, 40-59 years n = 4788, 60-79 years n = 3221, 80+ years n = 1332. After the peak (March 22, 2020), incidence declined in older age groups and increased among age 0-19 and 20-39 age groups from 20% to 40% of total cases by April 19 and 50% by May 3. During this time testing expanded with more testing among older age groups and less testing among younger age groups while case positivity shifted young. Percent positive cases age 0-19/20-39 years through August 2020 increased to a consistent average of 60% [age 0-19 increased to 19% (N = 10257), age 20-39 increased to 42% (N = 30215)]. CONCLUSIONS: An increased sustained proportion of COVID-19 incidence is present among children (age 0-19) and young adults (age 20-39) indicating an elevated role in disease spread during the epidemic creating a possible reservoir of disease with spillover risk to more vulnerable older persons and those with comorbid conditions. Media savvy age-appropriate messaging to enhance mitigation compliance among less vulnerable, more mobile and lower priority vaccination age groups will be a continued necessity and priority to reduce overall population incidence.
BACKGROUND: As the coronavirus (COVID-19) epidemic passed initial infection peak in Washington State, phased re-opening lifted stay-at-home orders and restrictions leading to increased non-essential work, social activities and gathering, especially among younger persons. METHODS: A longitudinal cohort analysis of Washington State Department of Health COVID-19 confirmed case age distribution 1) March-April 2020 (N = 13,934) and 2) March-August 2020 (N = 76,032) for proportional change over time using chi square tests for significance. RESULTS: From March 1st to April 19, 2020 COVID-19age distribution shifted with a 10% decline in cases age 60 years and older and a 20% increase in age 0-19/20-39 years (chi-square = 223.10, p < .001). Number of cases over the initial analysis period were 0-19 years n = 515, 20-39 years n = 4078, 40-59 years n = 4788, 60-79 years n = 3221, 80+ years n = 1332. After the peak (March 22, 2020), incidence declined in older age groups and increased among age 0-19 and 20-39 age groups from 20% to 40% of total cases by April 19 and 50% by May 3. During this time testing expanded with more testing among older age groups and less testing among younger age groups while case positivity shifted young. Percent positive cases age 0-19/20-39 years through August 2020 increased to a consistent average of 60% [age 0-19 increased to 19% (N = 10257), age 20-39 increased to 42% (N = 30215)]. CONCLUSIONS: An increased sustained proportion of COVID-19 incidence is present among children (age 0-19) and young adults (age 20-39) indicating an elevated role in disease spread during the epidemic creating a possible reservoir of disease with spillover risk to more vulnerable older persons and those with comorbid conditions. Media savvy age-appropriate messaging to enhance mitigation compliance among less vulnerable, more mobile and lower priority vaccination age groups will be a continued necessity and priority to reduce overall population incidence.
Authors: Michelle L Holshue; Chas DeBolt; Scott Lindquist; Kathy H Lofy; John Wiesman; Hollianne Bruce; Christopher Spitters; Keith Ericson; Sara Wilkerson; Ahmet Tural; George Diaz; Amanda Cohn; LeAnne Fox; Anita Patel; Susan I Gerber; Lindsay Kim; Suxiang Tong; Xiaoyan Lu; Steve Lindstrom; Mark A Pallansch; William C Weldon; Holly M Biggs; Timothy M Uyeki; Satish K Pillai Journal: N Engl J Med Date: 2020-01-31 Impact factor: 91.245
Authors: Noah G Schwartz; Anne C Moorman; Anna Makaretz; Karen T Chang; Victoria T Chu; Christine M Szablewski; Anna R Yousaf; Marie M Brown; Ailis Clyne; Amanda DellaGrotta; Jan Drobeniuc; Jacqueline Korpics; Adam Muir; Cherie Drenzek; Utpala Bandy; Hannah L Kirking; Jacqueline E Tate; Aron J Hall; Tatiana M Lanzieri; Rebekah J Stewart Journal: MMWR Morb Mortal Wkly Rep Date: 2020-10-09 Impact factor: 17.586
Authors: Tegan K Boehmer; Jourdan DeVies; Elise Caruso; Katharina L van Santen; Shichao Tang; Carla L Black; Kathleen P Hartnett; Aaron Kite-Powell; Stephanie Dietz; Matthew Lozier; Adi V Gundlapalli Journal: MMWR Morb Mortal Wkly Rep Date: 2020-10-02 Impact factor: 17.586
Authors: Rebecca F Wilson; Andrea J Sharma; Sarahjean Schluechtermann; Dustin W Currie; Joan Mangan; Brian Kaplan; Kimberly Goffard; Julia Salomon; Sue Casteel; Ashley Mukasa; Niki Euhardy; Andrew Ruiz; Gregory Bautista; Erika Bailey; Ryan Westergaard; Douglas Gieryn Journal: MMWR Morb Mortal Wkly Rep Date: 2020-10-16 Impact factor: 17.586
Authors: Jeremy A W Gold; Lauren M Rossen; Farida B Ahmad; Paul Sutton; Zeyu Li; Phillip P Salvatore; Jayme P Coyle; Jennifer DeCuir; Brittney N Baack; Tonji M Durant; Kenneth L Dominguez; S Jane Henley; Francis B Annor; Jennifer Fuld; Deborah L Dee; Achuyt Bhattarai; Brendan R Jackson Journal: MMWR Morb Mortal Wkly Rep Date: 2020-10-23 Impact factor: 17.586
Authors: Ana A Weil; Sarah L Sohlberg; Jessica A O'Hanlon; Amanda M Casto; Anne W Emanuels; Natalie K Lo; Emily P Greismer; Ariana M Magedson; Naomi C Wilcox; Ashley E Kim; Lewis Back; Christian D Frazar; Ben Pelle; Thomas R Sibley; Misja Ilcisin; Jover Lee; Erica L Ryke; J Chris Craft; Kristen M Schwabe-Fry; Kairsten A Fay; Shari Cho; Peter D Han; Sarah J Heidl; Brian A Pfau; Melissa Truong; Weizhi Zhong; Sanjay R Srivatsan; Katia F Harb; Geoffrey S Gottlieb; James P Hughes; Deborah A Nickerson; Christina M Lockwood; Lea M Starita; Trevor Bedford; Jay A Shendure; Helen Y Chu Journal: Open Forum Infect Dis Date: 2021-09-17 Impact factor: 3.835
Authors: Rebecca K Borchering; Luke C Mullany; Emily Howerton; Matteo Chinazzi; Claire P Smith; Michelle Qin; Nicholas G Reich; Lucie Contamin; John Levander; Jessica Kerr; J Espino; Harry Hochheiser; Kaitlin Lovett; Matt Kinsey; Kate Tallaksen; Shelby Wilson; Lauren Shin; Joseph C Lemaitre; Juan Dent Hulse; Joshua Kaminsky; Elizabeth C Lee; Jessica T Davis; Kunpeng Mu; Xinyue Xiong; Ana Pastore Y Piontti; Alessandro Vespignani; Ajitesh Srivastava; Przemyslaw Porebski; Srini Venkatramanan; Aniruddha Adiga; Bryan Lewis; Brian Klahn; Joseph Outten; Benjamin Hurt; Jiangzhuo Chen; Henning Mortveit; Amanda Wilson; Madhav Marathe; Stefan Hoops; Parantapa Bhattacharya; Dustin Machi; Shi Chen; Rajib Paul; Daniel Janies; Jean-Claude Thill; Marta Galanti; Teresa Yamana; Sen Pei; Jeffrey Shaman; Guido Espana; Sean Cavany; Sean Moore; Alex Perkins; Jessica M Healy; Rachel B Slayton; Michael A Johansson; Matthew Biggerstaff; Katriona Shea; Shaun A Truelove; Michael C Runge; Cécile Viboud; Justin Lessler Journal: medRxiv Date: 2022-03-10
Authors: L Aliberti; I Gagliardi; S Lupo; M Verrienti; M Bondanelli; M C Zatelli; M R Ambrosio Journal: J Endocrinol Invest Date: 2022-01-22 Impact factor: 4.256